Athira Pharma Rg

Athira Pharma, a clinical‑stage biopharma, develops small‑molecule therapies restoring neuronal health. Its pipeline targets ALS, Alzheimer’s and other neurodegenerative diseases, with ATH‑1105 in phase 1 and multiple candidates in preclinical and early trials.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Professional Services
Industry: Biotechnology Research

Employees: 26
HQ: Bothell

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
ATHA	Athira Pharma Rg Cap: 0.0B	EQUITY	NMS	USD	US04746L1044	Active	📈